Grossing and reporting of testicular tumor specimens : An evidence-based approach

The majority of testicular tumors are germ cell tumors (GCTs), but there are numerous other types, making testicular tumors one of the most diverse areas of human pathology, despite their relative rarity. Testicular tumors are usually diagnosed only after radical surgery, as biopsies are not performed. Further management of the patient is dependent on the diagnosis at microscopy, which itself is based on the sections taken at the time of grossing the specimen. Many pathologists often aren′t well versed with guidelines for handling of orchiectomy specimens and for microscopy. This article discusses, in detail, the approach to grossing of a testicular tumor specimen and elaborates of the reasons as to why we do what we do at the initial “cut-up”. It explains the logic behind the reporting guidelines for testicular tumors and offer a clinical primer to the pathologist as to why we do what we do while grossing testicular tumor specimens.

[1]  E. Bass,et al.  Diagnosis and Treatment of Early Stage Testicular Cancer: AUA Guideline. , 2019, The Journal of urology.

[2]  J. Heinzelbecker Treatment of Local Disease in Testicular Cancer , 2019, Urologic Oncology.

[3]  P. Albers,et al.  Testicular tumour size and rete testis invasion as prognostic factors for the risk of relapse of clinical stage I seminoma testis patients under surveillance: A systematic review by the Testicular Cancer Guidelines Panel , 2018 .

[4]  D. Berney,et al.  Reporting and Staging of Testicular Germ Cell Tumors: The International Society of Urological Pathology (ISUP) Testicular Cancer Consultation Conference Recommendations. , 2017, The American journal of surgical pathology.

[5]  G. Gautam,et al.  Current Concepts in Management of Stage I NSGCT , 2017, Indian Journal of Surgical Oncology.

[6]  B. Delahunt,et al.  Handling and reporting of orchidectomy specimens with testicular cancer: areas of consensus and variation among 25 experts and 225 European pathologists , 2015, Histopathology.

[7]  P. Warde,et al.  Lymph Node Yield in Primary Retroperitoneal Lymph Node Dissection for Nonseminoma Germ Cell Tumors. , 2015, The Journal of urology.

[8]  S. Hancock,et al.  Testicular Cancer, Version 2.2015. , 2015, Journal of the National Comprehensive Cancer Network : JNCCN.

[9]  K. Trpkov,et al.  Testicular hilum and vascular invasion predict advanced clinical stage in nonseminomatous germ cell tumors , 2013, Modern Pathology.

[10]  A. Horwich,et al.  Update on management of seminoma , 2010, Indian journal of urology : IJU : journal of the Urological Society of India.

[11]  F. Algaba,et al.  EAU Guidelines on Testicular Cancer , 2001, European Urology.

[12]  T. Ulbright Protocol for the examination of specimens from patients with malignant germ cell and sex cord-stromal tumors of the testis, exclusive of paratesticular malignancies: a basis for checklists. Cancer Committee, College of American Pathologists. , 2009, Archives of pathology & laboratory medicine.

[13]  R. Epstein,et al.  Long-term results of autologous marrow transplantation for relapsed or refractory male or female germ cell tumors , 1998, Bone Marrow Transplantation.

[14]  Richard Sylvester,et al.  International germ cell consensus classification: A prognostic factor-erased staging system for metastatic germ cell cancers , 1997 .

[15]  J. Ro,et al.  Spermatic cord contamination in testicular cancer. , 1996, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[16]  A. Horwich,et al.  Medical Research Council prospective study of surveillance for stage I testicular teratoma. Medical Research Council Testicular Tumors Working Party. , 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  A. Horwich,et al.  Surveillance following orchidectomy for stage I testicular seminoma. , 1992, British Journal of Cancer.

[18]  C. Logothetis,et al.  Clinical Stage I Nonseminomatous and Mixed Germ Cell Tumors of the Testis: A Clinicopathologic Study of 93 Patients on a Surveillance Protocol after Orchiectomy Alone , 1989 .

[19]  N. Skakkebaek,et al.  Carcinoma in situ of contralateral testis in patients with testicular germ cell cancer: study of 27 cases in 500 patients. , 1986, British medical journal.